Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

To lead or lag?

R M Williams

    Foundation News
    |December 10, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Health care policy is a critical emerging issue. This study examines whether health funders should actively advocate for solutions alongside their exploration efforts.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Prospective Phase I/II Study of Docetaxel, Cisplatin and Continuous Capecitabine in Advanced Oesophago-Gastric Cancer (NWCOG-3).

    Clinical oncology (Royal College of Radiologists (Great Britain))·2018
    Same author

    Development of a low-level <sup>39</sup>Ar calibration standard - Analysis by absolute gas counting measurements augmented with simulation.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2017
    Same author

    First results of a simultaneous measurement of tritium and (14)C in an ultra-low-background proportional counter for environmental sources of methane.

    Journal of environmental radioactivity·2016
    Same author

    Shielding concepts for low-background proportional counter arrays in surface laboratories.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2016
    Same author

    Development of a low-level (37)Ar calibration standard.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2015
    Same author

    Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

    Natural product reports·2014
    Same journal

    Why nonprofits don't measure cost-effectiveness.

    Foundation news·1992
    Same journal

    Consultants listings.

    Foundation news·1992
    Same journal

    Calculating consultant costs.

    Foundation news·1992
    Same journal

    Three for the money.

    Foundation news·1991
    Same journal

    Rationing: the unspoken issue.

    Foundation news·1991
    Same journal

    Finding a niche in the vast field of health care.

    Foundation news·1991
    See all related articles

    Area of Science:

    • Health Policy
    • Philanthropy
    • Public Health

    Background:

    • Health care policy is a rapidly evolving and critical issue.
    • Major philanthropic foundations are adapting to address these challenges.
    • A key debate exists regarding the role of health funders in policy advocacy.

    Purpose of the Study:

    • To explore the question of whether health funders should engage in policy advocacy.
    • To analyze the dual role of exploring solutions and advocating for them.

    Main Methods:

    • Literature review on foundation practices in health policy.
    • Analysis of case studies on philanthropic engagement.
    • Discussion of ethical and strategic considerations for advocacy.

    Related Experiment Videos

    Main Results:

    • Foundations are increasingly involved in health policy.
    • The decision to advocate involves complex strategic and ethical considerations.
    • Evidence suggests advocacy can amplify impact but carries risks.

    Conclusions:

    • The role of health funders in policy advocacy requires careful consideration.
    • Foundations must weigh potential benefits against risks when deciding to advocate.
    • Further research is needed to define best practices for philanthropic advocacy in health policy.